CASE REPORT: THE POSSIBILITY OF SPECIFIC THERAPY OPTIMIZATION BY SWITCHING FROM BOSENTAN TO MACITENTAN IN A PATIENT WITH CONGENITAL HEART DISEASE AND EISENMENGER SYNDROME by S. Ye. Gratsianakaya, O. A. Arkhipova, A. I. Davydov, T. V. Martynyuk, N. A. Ananicheva, O. S. Belkorey, I. Ye. Chazova

Subjects: Get full text

Macitentan in the treatment of pulmonary hypertension in Gaucher's disease by Gokay Taylan, Meryem Aktoz, Mehmet Celik, Mustafa Yılmaztepe

Subjects: Get full text

The endothelin receptor antagonist macitentan ameliorates endothelin-mediated vasoconstriction and promotes the survival of retinal ganglion cells in rats by Bindu Kodati, Bindu Kodati, Wei Zhang, Wei Zhang, Shaoqing He, Jennifer H. Pham, Jennifer H. Pham, Kallen J. Beall, Zoe E. Swanger, Vignesh R. Krishnamoorthy, Payton E. Harris, Trent Hall, Ashley V. Tran, Renuka M. Chaphalkar, Sai H. Chavala, Dorota L. Stankowska, Dorota L. Stankowska, Raghu R. Krishnamoorthy, Raghu R. Krishnamoorthy

Subjects: Get full text

Benefits of Macitentan in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Jinlv Qin, Guizuo Wang, Dong Han

Subjects: “…macitentan…”
Get full text

Anti-inflammatory effects of endothelin receptor blockade in left atrial tissue of spontaneously hypertensive rats by A. Bukowska, Y. Nikonova, C. Wolke, U. Lendeckel, J. Kockskämper, A. Goette

Subjects: Get full text

Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension by Monaco TJ, Davila CD

Subjects: Get full text

Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review by Niuniu Li, Qiang Wu, Juan Meng, Cheng Feng, Siwei Jiang, Meixia Chen, Wenhui Xu, Fei Wang, Yifan Zhang, Juncai Liu, Cheng Xu, Gaolin Liu, Hong Gao

Subjects: Get full text

Protective effect of triclosan in monocrotaline-induced pulmonary arterial hypertension: FASN inhibition a novel approach by Nimer Alsabeelah, Vinay Kumar

Subjects: Get full text

A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension by O A Arkhipova, T V Martynyuk, I E Chazova

Subjects: Get full text

Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension by Richard Channick, MD, Sarah Medrek, MD, Marion Delcroix, MD, Sean Gaine, MD, Pavel Jansa, MD, PhD, Irene Lang, MD, Vallerie McLaughlin, MD, Sanjay Mehta, MD, Tomas Pulido, MD, Bhagavatula Sastry, MD, Rogerio Souza, MD, PhD, Adam Torbicki, MD, Carol Zhao, MS, Paul Strachan, MD, Peter Agron, PhD, Joseph Yen, PhD, Olivier Sitbon, MD, PhD

Subjects: Get full text

Efficacy and safety of macitentan for pulmonary hypertension: A meta‐analysis by Dan Du, Ya‐Dong Yuan

Subjects: Get full text

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update by Wong AK, Channick RN

Subjects: “…Macitentan…”
Get full text

The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension by S N Avdeev

Subjects: Get full text

Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT) by Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi

Subjects: Get full text

Improvement in idiopathic interstitial pneumonia by adding macitentan to a patient unresponsive to nintedanib by Yosuke Tanaka, Shota Kaburaki, Toru Tanaka, Koichiro Kamio, Tetsuya Okano, Masahiro Seike

Subjects: “…Macitentan…”
Get full text

Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension by S N Avdeev

Subjects: Get full text

Leflunomide-induced pulmonary arterial hypertension in a young man with nephrotic syndrome: A case report by Xiaoqin Luo, Jiang Li, Sisi Chen, Jun Luo

Subjects: Get full text

EXPERIENCE OF USING THE NON­SELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION by M. A. Simakova, N. S. Goncharova, E. V. Karelkina, O. M. Moiseeva

Subjects: Get full text

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study by Pilar Escribano-Subias, Raquel López, Luis Almenar, María Lázaro, Ian Forn, Anna Torrent, Isabel Blanco, Joan Albert Barberà, on behalf of the PRACMA investigators

Subjects: “…Macitentan…”
Get full text

Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic by Dénes Csonka, Vladislav Fishman, Jaya Natarajan, Hans Stieltjes, Danielle Armas, Victor Dishy, Juan Jose Perez Ruixo

Subjects: Get full text